Cargando…
Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model
Cauda equina compression (CEC) is a major cause of neurogenic claudication and progresses to neuropathic pain (NP). A lipid mediator, lysophosphatidic acid (LPA), is known to induce NP via the LPA(1) receptor. To know a possible mechanism of LPA production in neurogenic claudication, we determined t...
Autores principales: | Uranbileg, Baasanjav, Ito, Nobuko, Kurano, Makoto, Saigusa, Daisuke, Saito, Ritsumi, Uruno, Akira, Kano, Kuniyuki, Ikeda, Hitoshi, Yamada, Yoshitsugu, Sumitani, Masahiko, Sekiguchi, Miho, Aoki, Junken, Yatomi, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851136/ https://www.ncbi.nlm.nih.gov/pubmed/31719574 http://dx.doi.org/10.1038/s41598-019-52999-5 |
Ejemplares similares
-
Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study
por: Kuwajima, Ken, et al.
Publicado: (2018) -
Inhibition of autotaxin activity ameliorates neuropathic pain derived from lumbar spinal canal stenosis
por: Uranbileg, Baasanjav, et al.
Publicado: (2021) -
Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis
por: Hayakawa, Kentaro, et al.
Publicado: (2019) -
Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains
por: Kurano, Makoto, et al.
Publicado: (2022) -
Different Profiles of the Triad of Lysophosphatidylcholine, Lysophosphatidic Acid, and Autotaxin in Patients with Neuropathic Pain Diseases: a Preliminary Observational Study
por: Edamura, Tatsuma, et al.
Publicado: (2022)